Strides Pharma Science reaches all-time high, outperforms Sensex in strong market performance

Strides Pharma Science, a midcap pharmaceutical company, has recently seen a surge in its stock price, reaching an all-time high on October 10, 2024. The stock has been performing well in the market, with a 'Hold' recommendation from MarketsMOJO.

According to MarketsMOJO, Strides Pharma Science is part of the Momentumnow Stocks and has been listed since April 3, 2024. The stock is currently trading close to its 52-week high of Rs 1530, with a performance today that is in line with the sector. It has also been gaining for the last three days, with a 7.09% increase in returns during this period.

The stock has shown high volatility today, with an intraday volatility of 67.58% calculated from the weighted average price. However, Strides Pharma is still trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages.

In terms of performance, Strides Pharma has outperformed the Sensex by a significant margin, with a 1-year performance of 201.79% compared to the Sensex's 23.55%. This showcases the company's strong growth and potential in the pharmaceutical industry.

As a midcap company, Strides Pharma Science has established itself as a key player in the pharmaceutical and drugs sector. With its recent surge in stock price and positive performance, it is definitely a company to watch out for in the market.